Single cell genomics in breast cancer: breast tumour evolution and intra-tumour heterogeneity

SABCS 2018: Highlights in breast cancer treatment

Prognostic value of circulating tumour-cell count in metastatic breast cancer patients

Clinical impact of an accurate genetic characterisation of older AML patients

Accelerated partial breast irradiation not equivalent to whole breast irradiation

Circulating tumour-cell count used to decide between treatments for breast cancer patients

Recent data on eribulin in metastatic breast cancer patients from SABCS 2018

Role of chemotherapy in the treatment of metastatic breast cancer patients

The combined analysis of carfilzomib trials for multiple myeloma

Landscape change with oral proteasome maintenance in multiple myeloma patients

Multiple myeloma highlights and more from ASH 2018

Results of the Beat AML umbrella study for previously untreated acute myeloid leukaemia